Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended December 29, 2019
FREMONT, Calif., January 29, 2020 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 29, 2019 (the “December 2019 quarter”).
Highlights for the December 2019 quarter were as follows:
•
Revenue of $2.58 billion.
•
U.S. GAAP gross margin of 45.7%, U.S. GAAP operating income as a percentage of revenue of 26.6%, and U.S. GAAP diluted EPS of $3.43.
•
Non-GAAP gross margin of 45.7%, non-GAAP operating income as a percentage of revenue of 27.1%, and non-GAAP diluted EPS of $4.01.
Key Financial Data for the Quarters Ended
December 29, 2019 and September 29, 2019
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
 
  
December 2019
 
September 2019
 
Change Q/Q
Revenue
  
$
2,583,501

 
$
2,165,746

 
+ 19%
Gross margin as percentage of revenue
  
45.7
%
 
45.3
%
 
+ 40 bps
Operating income as percentage of revenue
  
26.6
%
 
24.8
%
 
+ 180 bps
Diluted EPS
  
$
3.43

 
$
3.09

 
+ 11%
 
 
 
 
 
 
 
Non-GAAP
 
  
December 2019
 
September 2019
 
Change Q/Q
Revenue
  
$
2,583,501

 
$
2,165,746

 
+ 19%
Gross margin as percentage of revenue
  
45.7
%
 
45.4
%
 
+ 30 bps
Operating income as percentage of revenue
  
27.1
%
 
25.5
%
 
+ 160 bps
Diluted EPS
  
$
4.01

 
$
3.18

 
+ 26%

U.S. GAAP Financial Results
For the December 2019 quarter, revenue was $2,584 million, gross margin was $1,180 million, or 45.7% of revenue, operating expenses were $493 million, operating income was 26.6% of revenue, and net income was $515 million, or $3.43 per diluted share on a U.S. GAAP basis. This compares to revenue of $2,166 million, gross margin of $982 million, or 45.3% of revenue, operating expenses of $444 million, operating income of 24.8% of revenue, and net income of $466 million, or $3.09 per diluted share, for the quarter ended September 29, 2019 (the “September 2019 quarter”).
Non-GAAP Financial Results
For the December 2019 quarter, non-GAAP gross margin was $1,181 million or 45.7% of revenue, non-GAAP operating expenses were $481 million, non-GAAP operating income was 27.1% of revenue, and non-GAAP net income was $602 million, or $4.01 per diluted share. This compares to non-GAAP gross margin of $983 million or 45.4% of revenue, non-GAAP operating expenses of $431 million, non-GAAP operating income of 25.5% of revenue, and non-GAAP net income of $480 million, or $3.18 per diluted share for the September 2019 quarter.
“Lam closed out calendar 2019 with strong December quarter results,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “We are executing at a high level in an improving wafer fabrication equipment environment and building a powerful pipeline of new products to fuel future growth.”









Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $4.9 billion at the end of the December 2019 quarter compared to $5.8 billion at the end of the September 2019 quarter. This decrease was primarily the result of $1.0 billion of share repurchases, including net share settlement on employee stock-based compensation, $166.7 million of dividends paid to stockholders, and $62.1 million of capital expenditures, partially offset by $307.9 million of cash generated from operating activities.

Deferred revenue and deferred profit at the end of the December 2019 quarter decreased to $411 million and $366 million, respectively, as compared to $481 million and $407 million, respectively, at the end of the September 2019 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $91 million as of December 29, 2019 and $47 million as of September 29, 2019.
Geographic Distribution
The geographic distribution of revenue during the December 2019 quarter is shown in the following table:
Region
Revenue
China
29%
Taiwan
26%
Korea
18%
United States
9%
Japan
8%
Southeast Asia
7%
Europe
3%
Outlook
For the quarter ended March 29, 2020, Lam is providing the following guidance:
 
U.S. GAAP
 
Reconciling Items
 
Non-GAAP
Revenue
$2.8 Billion
+/-
$200 Million
 
—
 
$2.8 Billion
+/-
$200 Million
Gross margin as a percentage of revenue
46.4%
+/-
1%
 
$
2

Million
 
46.5%
+/-
1%
Operating income as a percentage of revenue
27.5%
+/-
1%
 
$
14

Million
 
28.0%
+/-
1%
Net income per diluted share
$4.46
+/-
$0.40
 
$
13

Million
 
$4.55
+/-
$0.40
Diluted share count
149 Million
 
—
 
149 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
•
Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $2 million.
•
Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $14 million.
•
Net income per diluted share - amortization related to intangible assets acquired though business combinations, $14 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $13 million.




Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the December 2019 and September 2019 quarters exclude amortization related to intangible assets acquired through business combinations, amortization of note discounts, and income tax benefit of non-GAAP items. Additionally, the December 2019 quarter non-GAAP results exclude the cumulative income tax benefit reversal due to the Ninth Circuit decision to deny a rehearing of the Altera stock-based compensation case and the September 2019 quarter non-GAAP results exclude restructuring charges.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: the estimated future revenue from shipments to customers in Japan; the timing and amount of revenue and profit earned from any booked deferred revenue and profit; our continuing ability to execute; improvement in the wafer fabrication equipment environment; our ability to develop successful new products and the potential for those products to fuel future growth; the legal and business factors that may affect our future tax rate; and our guidance for revenue, gross margin (both as a dollar value and a percentage of revenue), operating income (both as a dollar value and a percentage of revenue), net income or earnings per diluted share, on either a GAAP or non-GAAP basis and diluted share count. Some factors that may affect these forward-looking statements include: business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 30, 2019 and our quarterly report on Form 10-Q for the fiscal quarter ended September 29, 2019. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
About Lam Research
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. As a trusted, collaborative partner to the world’s leading semiconductor companies, we combine superior systems engineering capability, technology leadership, and unwavering commitment to customer success to accelerate innovation through enhanced device performance. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.
 ###






 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 
 
Three Months Ended
 
Six Months Ended
 
December 29,
2019
 
September 29,
2019
 
December 23,
2018
 
December 29,
2019
 
December 23,
2018
Revenue
$
2,583,501

 
$
2,165,746

 
$
2,522,673

 
$
4,749,247

 
$
4,853,364

Cost of goods sold
1,403,857

 
1,184,036

 
1,377,640

 
2,587,893

 
2,650,133

Gross margin
1,179,644

 
981,710

 
1,145,033

 
2,161,354

 
2,203,231

Gross margin as a percent of revenue
45.7
%
 
45.3
%
 
45.4
%
 
45.5
%
 
45.4
%
Research and development
318,861

 
286,827

 
285,556

 
605,688

 
577,228

Selling, general and administrative
174,272

 
157,428

 
169,098

 
331,700

 
343,873

Total operating expenses
493,133

 
444,255

 
454,654

 
937,388

 
921,101

Operating income
686,511

 
537,455

 
690,379

 
1,223,966

 
1,282,130

Operating income as a percent of revenue
26.6
%
 
24.8
%
 
27.4
%
 
25.8
%
 
26.4
%
Other expense, net
(13,924
)
 
(12,728
)
 
(30,649
)
 
(26,652
)
 
(31,026
)
Income before income taxes
672,587

 
524,727

 
659,730

 
1,197,314

 
1,251,104

Income tax expense
(158,077
)
 
(58,938
)
 
(90,875
)
 
(217,015
)
 
(148,889
)
Net income
$
514,510

 
$
465,789

 
$
568,855

 
$
980,299

 
$
1,102,215

Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
3.57

 
$
3.22

 
$
3.67

 
$
6.79

 
$
7.10

Diluted
$
3.43

 
$
3.09

 
$
3.51

 
$
6.52

 
$
6.73

Number of shares used in per share calculations:
 
 
 
 
 
 
 
 
 
Basic
143,987

 
144,673

 
155,022

 
144,330

 
155,340

Diluted
150,097

 
150,682

 
162,170

 
150,389

 
163,749

Cash dividend declared per common share
$
1.15

 
$
1.15

 
$
1.10

 
$
2.30

 
$
2.20


 
















 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
 
December 29,
2019
 
September 29,
2019
 
June 30,
2019
 
(unaudited)
 
(unaudited)
 
(1)
ASSETS
 
 
 
 
 
Cash and cash equivalents
$
3,035,887

 
$
4,607,182

 
$
3,658,219

Investments
1,647,867

 
983,650

 
1,772,984

Accounts receivable, net
2,030,490

 
1,635,643

 
1,455,522

Inventories
1,528,620

 
1,483,385

 
1,540,140

Prepaid expenses and other current assets
212,101

 
124,755

 
133,544

Total current assets
8,454,965

 
8,834,615

 
8,560,409

Property and equipment, net
1,047,254

 
1,030,168

 
1,059,077

Restricted cash and investments
253,907

 
254,654

 
255,177

Goodwill and intangible assets
1,677,940

 
1,690,648

 
1,701,547

Other assets
480,056

 
533,417

 
425,123

Total assets
$
11,914,122

 
$
12,343,502

 
$
12,001,333

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
Current portion of long-term debt and finance lease obligations
$
632,292

 
$
645,158

 
$
667,131

Other current liabilities
1,933,209

 
1,812,524

 
1,704,519

Total current liabilities
2,565,501

 
2,457,682

 
2,371,650

Long-term debt and finance lease obligations
3,786,067

 
3,788,089

 
3,822,768

Income taxes payable
872,778

 
856,895

 
892,790

Other long-term liabilities
272,043

 
261,890

 
190,821

Total liabilities
7,496,389

 
7,364,556

 
7,278,029

Temporary equity, convertible notes
38,304

 
42,553

 
49,439

Stockholders’ equity (2)
4,379,429

 
4,936,393

 
4,673,865

Total liabilities and stockholders’ equity
$
11,914,122

 
$
12,343,502

 
$
12,001,333

 
(1)
Derived from audited financial statements.
(2)
Common shares issued and outstanding were 142,462 as of December 29, 2019, 144,871 as of September 29, 2019, and 144,433 as of June 30, 2019.
 






 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
 
Three Months Ended
 
Six Months Ended
 
December 29,
2019
 
September 29,
2019
 
December 23,
2018
 
December 29,
2019
 
December 23,
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net income
$
514,510

 
$
465,789

 
$
568,855

 
$
980,299

 
$
1,102,215

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
 
 
 
Depreciation and amortization
65,530

 
64,664

 
81,794

 
130,194

 
161,599

Deferred income taxes
77,508

 
(2,992
)
 
20,797

 
74,516

 
(62,704
)
Equity-based compensation expense
45,725

 
42,905

 
38,806

 
88,630

 
89,149

Amortization of note discounts and issuance costs
1,575

 
1,675

 
1,031

 
3,250

 
2,276

Other, net
(327
)
 
4,026

 
(1,343
)
 
3,699

 
848

Changes in operating assets and liabilities
(396,593
)
 
(112,020
)
 
(67,521
)
 
(508,613
)
 
69,322

Net cash provided by operating activities
307,928

 
464,047

 
642,419

 
771,975

 
1,362,705

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Capital expenditures and intangible assets
(62,054
)
 
(39,256
)
 
(105,923
)
 
(101,310
)
 
(162,021
)
Net (purchase) sale of available-for-sale securities
(662,287
)
 
790,478

 
773,223

 
128,191

 
160,640

Other, net
(9,988
)
 
(540
)
 
(369
)
 
(10,528
)
 
(4,019
)
Net cash (used for) provided by investing activities
(734,329
)
 
750,682

 
666,931

 
16,353

 
(5,400
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Principal payments on debt
(17,987
)
 
(28,965
)
 
(6,440
)
 
(46,952
)
 
(86,271
)
Net repayments of commercial paper
—

 
—

 
(359,518
)
 
—

 
(359,604
)
Treasury stock purchases
(1,005,067
)
 
(78,132
)
 
(1,519
)
 
(1,083,199
)
 
(1,737,414
)
Dividends paid
(166,721
)
 
(158,868
)
 
(167,907
)
 
(325,589
)
 
(342,279
)
Reissuance of treasury stock related to employee stock purchase plan
38,447

 
—

 
32,920

 
38,447

 
32,920

Proceeds from issuance of common stock
632

 
3,869

 
109

 
4,501

 
109

Other, net
—

 
—

 
(13,198
)
 
—

 
(13,207
)
Net cash used for financing activities
(1,150,696
)
 
(262,096
)
 
(515,553
)
 
(1,412,792
)
 
(2,505,746
)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
5,055

 
(4,193
)
 
(2,721
)
 
862

 
(5,032
)
Net (decrease) increase in cash, cash equivalents, and restricted cash
(1,572,042
)
 
948,440

 
791,076

 
(623,602
)
 
(1,153,473
)
Cash, cash equivalents, and restricted cash at beginning of period
4,861,836

 
3,913,396

 
2,824,009

 
3,913,396

 
4,768,558

Cash, cash equivalents, and restricted cash at end of period
$
3,289,794

 
$
4,861,836

 
$
3,615,085

 
$
3,289,794

 
$
3,615,085

                          





 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
 
Three Months Ended
 
December 29,
2019
 
September 29,
2019
Revenue
$
2,583,501

 
$
2,165,746

Gross margin
$
1,181,271

 
$
983,338

Gross margin as percentage of revenue
45.7
%
 
45.4
%
Operating expenses
$
480,776

 
$
430,853

Operating income
$
700,495

 
$
552,485

Operating income as a percentage of revenue
27.1
%
 
25.5
%
Net income
$
601,810

 
$
479,555

Net income per diluted share
$
4.01

 
$
3.18

Shares used in per share calculation - diluted
150,097

 
150,682

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
 
Three Months Ended
 
December 29, 2019
 
September 29,
2019
U.S. GAAP net income
$
514,510

 
$
465,789

Pre-tax non-GAAP items:
 
 
 
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold
1,627

 
1,628

Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative
12,357

 
12,357

Restructuring charges - selling, general and administrative
—

 
1,045

Amortization of note discounts - other expense, net
1,158

 
1,234

Net income tax benefit on non-GAAP items
(2,358
)
 
(2,498
)
Cumulative income tax benefit reversal due to a court ruling
74,516

 
—

Non-GAAP net income
$
601,810

 
$
479,555

Non-GAAP net income per diluted share
$
4.01

 
$
3.18

U.S. GAAP net income per diluted share
$
3.43

 
$
3.09

U.S. GAAP and non-GAAP number of shares used for per diluted share calculation
150,097

 
150,682






 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
 
Three Months Ended
 
December 29,
2019
 
September 29,
2019
U.S. GAAP gross margin
$
1,179,644

 
$
981,710

Pre-tax non-GAAP items:
 
 
 
Amortization related to intangible assets acquired through certain business combinations
1,627

 
1,628

Non-GAAP gross margin
$
1,181,271

 
$
983,338

U.S. GAAP gross margin as a percentage of revenue
45.7
%
 
45.3
%
Non-GAAP gross margin as a percentage of revenue
45.7
%
 
45.4
%
U.S. GAAP operating expenses
$
493,133

 
$
444,255

Pre-tax non-GAAP items:
 
 
 
Amortization related to intangible assets acquired through certain business combinations
(12,357
)
 
(12,357
)
Restructuring charges
—

 
(1,045
)
Non-GAAP operating expenses
$
480,776

 
$
430,853

U.S. GAAP operating income
$
686,511

 
$
537,455

Non-GAAP operating income
$
700,495

 
$
552,485

U.S. GAAP operating income as percent of revenue
26.6
%
 
24.8
%
Non-GAAP operating income as a percent of revenue
27.1
%
 
25.5
%
 
Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com